June 30th 2023
Aerobic activity and muscle strengthening exercises reduced the risk of pneumonia or influenza mortality, even when the exercises were completed less frequently than recommended.
April 10th 2023
Can anakinra reduce inflammation and the need for mechanical ventilation in patients with severe COVID-19 pneumonia?
April 7th 2023
The pneumonia drug Atovaquone oral suspension, USP 750mg/5mL, has been voluntarily recalled due to potential Bacillus cereus contamination.
March 25th 2023
This week's hottest topics included the risks of proton pump inhibitors, rare tickborne disease, HIV vaccination, COVID-19 immunity from a common cold, and hydrocortisone for pneumonia.
March 21st 2023
After 28 days, hydrocortisone reduced the risk of mortality by 5.7% in severe community-acquired pneumonia patients.
Antimicrobial Stewardship After Patient Discharge Is Lacking
Among community-acquired pneumonia (CAP) outpatients, 49% were prescribed unnecessary antibiotics.
Few Readmissions After Hospitalization for CAP Are Avoidable
An analysis of readmissions after hospitalization with community-acquired pneumonia (CAP) in France found that few readmissions were avoidable, supporting criticism that the measure may lead to unfair penalties under pay-for-performance programs.
Antimicrobial Stewardship Education Reduces Antibiotic Prescriptions in COVID-19 Patients
Antimicrobial stewardship efforts, such as education for healthcare providers, significantly decreased community-acquired pneumonia antibiotic prescriptions in COVID-19 patients.
2 Clarke Drive Cranbury, NJ 08512